A Risk Factor Analysis for MRSA Ventilator-Associated Pneumonia to Guide Empiric Therapy in the Surgical Intensive Care Unit

Feeney Megan E,Lindsey David E,Vazquez Daniel E,Porter Kyle,Murphy Claire V
DOI: https://doi.org/10.23937/2474-3658/1510075
2019-04-05
Journal of Infectious Diseases and Epidemiology
Abstract:Methicillin resistant Staphylococcus aureus (MRSA) ventilator-associated pneumonia (VAP) is increasing in prevalence. Treatment of VAP has moved toward ensuring patients are adequately covered for MRSA and other MDROs while balancing the need for antimicrobial stewardship and appropriateness of empiric coverage of these organisms in the setting of increasing resistance rates. The objective of this study was to identify the incidence of and risk factors for MRSA VAP in surgical intensive care unit (SICU) patients as a means to better identify patients at risk who would benefit from MRSA coverage empirically.
What problem does this paper attempt to address?